Key statistics
On Thursday, Immunovia AB (publ) (IMMNOV:STO) closed at 0.58, 11.83% above the 52 week low of 0.5186 set on May 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.595 |
---|---|
High | 0.595 |
Low | 0.566 |
Bid | -- |
Offer | -- |
Previous close | 0.589 |
Average volume | 1.86m |
---|---|
Shares outstanding | 169.71m |
Free float | 131.71m |
P/E (TTM) | -- |
Market cap | 98.43m SEK |
EPS (TTM) | -1.30 SEK |
Data delayed at least 15 minutes, as of Nov 21 2024 17:00 GMT.
More ▼
- Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers
- Invitation to Immunovia's Q3 presentation
- Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
- Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
- Immunovia completes analytical validation of its next-generation pancreatic cancer test
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
More ▼